ASTER DM HEALTHCARE LTD Q3 RESULTS
Take notice! In a muted Q1 season, these 14 companies doubled sales and profits
14 companies with market capitalization exceeding Rs 2,500 crore demonstrated exceptional performance in Q1 2024, doubling their sales and profits. Top performers included Spright Agro and Diamond Power Infrastructure. The broader market saw mixed results with sectors like BFSI and automobile doing well, but oil marketing companies underperforming.
Q1 results shocker: 40 companies report more than 50% drop in profit
The profits of 40 Indian companies have plummeted by more than 50% in the June quarter, primarily due to higher raw material costs and unfavorable base effects. Notable names like Allcargo Logistics and Rajesh Exports saw drastic declines. Analysts suggest cautious investment strategies amid high market valuations and slowing profit growth.
Apollo 24/7 GMV to go up to Rs 1,000 cr per quarter over next 18 months: Suneeta Reddy
Apollo Hospitals' Suneeta Reddy forecasted a 5% price impact for next quarter, citing the recent muted performance from elections and a heatwave. Regional occupancy and margins varied, with Nashik serving as a referral center. Apollo 24/7 aims for Rs 1,000 crore quarterly in six quarters. AHLL is on an improving revenue trajectory despite new centers impacting margins.
Metropolis Q1 results: Net profit rises 31% to Rs 38 crore
The earnings for interest, tax, depreciation and ammortisation (EBITDA) before CSR and ESOP rose 20.2% YoY to Rs 80.5 crore in Q1. The EBITDA margin in Q1FY25 was 25%.
Dr Lal PathLabs Q1 Results: Profit rises 28% to Rs 106 crore on strong testing demand, beats estimates
Consolidated net profit rose 28% to 1.06 billion rupees (around $13 million) for the quarter ended June 30, beating analysts' estimate of 992.7 million rupees, per LSEG.
Q1 results today: Vedanta among 132 companies to announce earnings on Tuesday
During the first quarter earnings season, 132 companies, including PFC and Tata Power, were scheduled to announce their financial results. Vedanta's net profit was expected to range between Rs 2,197-3,060 crore, with revenue estimates between Rs 35,440-38,674 crore for June 2024. Different brokerages provided varying growth predictions.
- Go To Page 1
Max Healthcare Q1 Results: PAT rises marginally to Rs 295 crore
In comparison to the same quarter last year, the hospital chain reported a substantial 18% growth in gross revenue, totalling Rs 2,028 crore. This increase was primarily fuelled by a 7% rise in average revenue per occupied bed (ARPOB), reaching Rs 77,100 in Q1FY25. The company attributed the higher ARPOB to growth in oncology and general surgery, coupled with price adjustments in self-pay, insurance, and institutional segments. Notably, the net profit for the corresponding quarter in the previous year was Rs 291 crore.
Q1 results today: ITC, Tata Motors among 88 companies will announce earnings on Thursday
Earnings season commenced with 88 companies announcing results. Key highlights included ITC, Sun Pharma, Tata Motors, Adani Enterprises, and Zomato reporting. ITC and Dabur anticipated revenue growth from cigarettes, hotels, and FMCG segments. Tata Motors projected strong profit growth. Zomato maintained robust performance from prior quarters, offering promising outlooks.
Dabur Q1 Preview: Domestic volumes to drive revenue growth by 6% YoY; margins to expand
Dabur India’s revenue for Q1 2024 likely witnessed a 6% year-on-year growth, driven by rural market improvement and international business. Domestic volumes reportedly grew by 5-6%, with gross margins expected to improve by up to 200 bps YoY. Higher ad-spends were seen moderating EBITDA margins slightly.
Q1 results today: Maruti, M&M among 115 companies to announce earnings on Wednesday
Q1 results today: In the first quarter earnings season, 115 companies announced results, including Maruti, M&M, Coal India, Adani Power, Tata Steel, Ambuja, and Bank of Baroda. M&M and Maruti expected mixed revenue and profit changes, while Tata Steel's profit was predicted to rise notably amid a revenue drop. Several others also reported their quarterly performance.
Tech Mahindra Q1 Results: Profit jumps 23% YoY to Rs 851 crore, misses estimates
Tech Mahindra Q1 Results: Tech Mahindra reported a 23% year-on-year growth in consolidated net profit to Rs 851 crore for the June quarter, slightly below the expected Rs 892 crore. Revenue from operations declined 1% YoY to Rs 13,005 crore. Sequentially, profit after tax rose by 28% and revenue increased by 1%.
LTIMindtree Q1 Results: Cons PAT falls over 1% YoY to Rs 1,134 crore; revenue rises 5%
LTIMindtree Q1 Results: The company reported revenue from operations of Rs 9,143 crore for the quarter, marking a 3% sequential increase compared to the previous quarter. In USD terms, revenue reached $1,096.2 million, representing a 3.5% YoY growth and a 2.5% quarter-over-quarter (QoQ) increase.
Tata Elxsi Q1 Results: Net profit falls 3% YoY to Rs 184 crore
Tata Elxsi Q1 Results: Revenue from operations for the reporting period grew by 9% year-on-year, reaching Rs 926 crore compared to Rs 850 crore in the same period last year. Sequentially, net profit for the quarter dropped by 6% from Rs 196 crore in the preceding December quarter. However, revenues increased by 2% quarter-on-quarter. Total expenses for the first quarter rose by 13% year-on-year to Rs 706 crore, compared to Rs 624 crore in the same quarter last year.
ET Analysis: Indian hospital chains report revenue growth & expansion plans amidst regulatory concerns
Leading hospital chains in India have reported improved average revenue per operating bed (ARPOB) and profitability in the latest quarter, driven by better payer mix and cost control measures. Expansion plans are underway, with a focus on markets like Bengaluru and Mumbai, through asset-light models. Adjacent businesses such as diagnostics, virtual care, and digital healthcare platforms are also seeing growth. However, regulatory proposals to rationalize rates may pose risks to sector valuations.
Apollo Hospitals Q4 Results: Net profit rises 76% YoY to Rs 254 crore
Revenue grew 15% YoY to Rs.4,944 crore in Q4FY24. The earnings before interest, tax, depreciation and ammortisation (EBITDA), EBITDA rose 31% YoY to Rs.640 crore in Q4FY24. The EBITDA margins expanded 161 basis points YoY to 12.95%.
3M India Q4 Results: 'Post-it' maker posts profit rise; shares surge
3M INDIA-RESULTS/'Post-it' maker 3M India posts Q4 profit rise; shares surge
Max Healthcare Institute Q4 Results: PAT down 3% YoY to Rs 311 crore
Max Healthcare Institute Ltd on Wednesday reported a 2.81 per cent decline in profit after tax at Rs 311 crore in the fourth quarter ended March 31, 2024. The company had posted a Profit After Tax (PAT) of Rs 320 crore in the same quarter of the previous fiscal, Max Healthcare Institute said in a statement.
Max Healthcare Q4 Results: Net profit drops 3% YoY to Rs 311 crore
Max Healthcare's Q4FY24 net profit dips 3% YoY to Rs 311 crore, attributed to lower effective tax rate in Q4FY23 and new unit losses. Gross revenue rises 15% YoY to Rs 1,890 crore.
Technical Breakout Stocks: How to trade Aster DM Healthcare, Thermax and Exide Industries on Tuesday?
Sectorally, buying was seen in oil & gas and energy while selling was seen in IT, banks, capital goods, and power indices.
Aster DM Healthcare shares jump 14%, hit fresh record high on special dividend announcement
Aster DM Healthcare's Board approved the declaration of a special dividend of Rs 118/share payable to those shareholders whose names stand on the register of members of the company as of the record date of April 23, 2024
Our plan is to be among top three healthcare players in next 3-5 years: Nitish Shetty, Aster DM Healthcare
60% of that 1,700 beds are going to be brownfield projects. When I say brownfield, it is an expansion of the existing infrastructure, existing hospitals, adding additional beds to the existing hospitals.
Stocks in news: Vodafone Idea, Aster DM Healthcare, DMart, Vedanta, RBL Bank
DIFC Dubai Branch has arranged for syndicated term loan of $500 million ($400 million and Green Shoe of $100 million) in two tranches with tenure of 3 years and 5 years.
Aster DM completes separation of Gulf business, plans to add 1,700 beds in India in next 3 years
Aster DM Healthcare has finalized the separation of its India and Gulf (GCC) businesses. A consortium led by Fajr Capital acquired a 65% stake in Aster GCC, while the Moopen family retained 35%. In India, the family holds a 41.88% stake. The separation aims to enhance strategic and financial flexibility.
Olympus Capital Asia divests 9.8% stake in Aster DM Healthcare for Rs 1,978 cr
According to the bulk deal data available with the BSE, more than 4.42 crore equity shares of Aster DM Healthcare were sold by Olympus Capital Asia Investments and 45.59 lakh shares by Olympus ACF Pte Ltd of the company. In a separate deal, Capital Group acquired shares of Aditya Vision, a financial services company, for Rs 95 crore.
Aster DM shares fall 7% after PE firm Olympus likely offloaded 10% stake via block deal
Aster DM shares were trading amid strong volumes with nearly 59 lakh shares being traded on the NSE around 10:45 am and the total traded value of the shares standing at Rs 242.50 crore.
Aster DM in final stage of Gulf business sale
Aster is planning to add 1500 beds by FY27 and aims to be among the top 3 hospital chains in India. The expansion plan will encompass a mix of brownfield and greenfield projects, contributing to the company's growth strategy. The company has planned an outlay of Rs. 850-900 crore which will ensure robust financial support for driving the expansion.
Load More
